Physician profile
Gail Hedges
NPI 1366862617
$2,097.08
in general payments reported to CMS, 2019-2025
18 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $393 · 2022: $439 · 2023: $488 · 2024: $365 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $431.56 | 2021-2025 | Jardiance, Mounjaro, Trulicity |
| Novo Nordisk INC | $391.93 | 2021-2025 | Ozempic, Rybelsus, Tresiba |
| Astrazeneca Pharmaceuticals LP | $239.58 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.67 | 2021-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $177.60 | 2022-2024 | |
| Abbott Laboratories | $114.76 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $106.41 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $74.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $71.57 | 2023-2025 | |
| Amgen INC. | $50.35 | 2024-2025 | Otezla, Repatha, Otezla |
| Sanofi Pasteur INC. | $44.92 | 2023 | |
| Dynavax Technologies Corporation | $39.98 | 2022-2023 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $34.75 | 2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $32.25 | 2024 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $31.77 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $22.41 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $17.54 | 2022 | |
| Xeris Pharmaceuticals, INC. | $14.98 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Hedges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.